(-)-alpha-phellandrene increases expression ISO RGD:1345617 6480464 alpha phellandrene results in increased expression of ALDH1L2 mRNA CTD PMID:25075043 1,1-dichloroethene increases expression ISO RGD:1551620 6480464 vinylidene chloride results in increased expression of ALDH1L2 mRNA CTD PMID:26682919 1,2-dichloroethane increases expression ISO RGD:1551620 6480464 ethylene dichloride results in increased expression of ALDH1L2 mRNA CTD PMID:28960355 1,2-dimethylhydrazine decreases expression ISO RGD:1551620 6480464 1, 2-Dimethylhydrazine results in decreased expression of ALDH1L2 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of ALDH1L2 mRNA CTD PMID:25380136 10-formyltetrahydrofolic acid increases metabolic processing ISO RGD:1345617 6480464 ALDH1L2 protein results in increased metabolism of 10-formyltetrahydropteroylglutamic acid CTD PMID:21238436 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1551620 6480464 Tetrachlorodibenzodioxin affects the expression of ALDH1L2 mRNA CTD PMID:21570461 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO RGD:1345617 6480464 2 more ... CTD PMID:26705709 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of ALDH1L2 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of ALDH1L2 mRNA CTD PMID:21346803 4,4'-diaminodiphenylmethane decreases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of ALDH1L2 mRNA CTD PMID:25380136 4,4'-diaminodiphenylmethane increases expression ISO RGD:1551620 6480464 4, 4'-diaminodiphenylmethane results in increased expression of ALDH1L2 mRNA CTD PMID:18648102 5,6,7,8-tetrahydrofolic acid increases chemical synthesis ISO RGD:1345617 6480464 ALDH1L2 protein results in increased chemical synthesis of 5 more ... CTD PMID:21238436 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of ALDH1L2 mRNA CTD PMID:24780913 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of ALDH1L2 mRNA CTD PMID:31881176 acrylamide increases expression ISO RGD:1345617 6480464 Acrylamide results in increased expression of ALDH1L2 mRNA CTD PMID:32763439 aflatoxin B1 decreases expression ISO RGD:1551620 6480464 Aflatoxin B1 results in decreased expression of ALDH1L2 mRNA CTD PMID:19770486 aflatoxin B1 decreases methylation ISO RGD:1345617 6480464 Aflatoxin B1 results in decreased methylation of ALDH1L2 intron CTD PMID:30157460 all-trans-retinoic acid decreases expression ISO RGD:1345617 6480464 Tretinoin results in decreased expression of ALDH1L2 mRNA CTD PMID:23724009 , PMID:33167477 alpha-phellandrene increases expression ISO RGD:1345617 6480464 alpha phellandrene results in increased expression of ALDH1L2 mRNA CTD PMID:25075043 antimycin A increases expression ISO RGD:1551620 6480464 Antimycin A results in increased expression of ALDH1L2 mRNA CTD PMID:19304788 aristolochic acid A decreases expression ISO RGD:1345617 6480464 aristolochic acid I results in decreased expression of ALDH1L2 mRNA CTD PMID:33212167 arsane affects methylation ISO RGD:1345617 6480464 Arsenic affects the methylation of ALDH1L2 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1345617 6480464 Arsenic affects the methylation of ALDH1L2 gene CTD PMID:25304211 arsenite(3-) affects expression ISO RGD:1345617 6480464 arsenite affects the expression of ALDH1L2 mRNA CTD PMID:22959463 benzo[a]pyrene affects methylation ISO RGD:1345617 6480464 Benzo(a)pyrene affects the methylation of ALDH1L2 promoter CTD PMID:27901495 benzo[e]pyrene decreases methylation ISO RGD:1345617 6480464 benzo(e)pyrene results in decreased methylation of ALDH1L2 intron CTD PMID:30157460 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of ALDH1L2 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:1551620 6480464 bisphenol A results in decreased expression of ALDH1L2 mRNA CTD PMID:32156529 bisphenol A decreases expression ISO RGD:1345617 6480464 bisphenol A results in decreased expression of ALDH1L2 protein CTD PMID:34186270 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ALDH1L2 mRNA CTD PMID:30816183 bisphenol A increases expression ISO RGD:1345617 6480464 bisphenol A analog results in increased expression of ALDH1L2 mRNA, bisphenol A results in increased expression of ALDH1L2 mRNA CTD PMID:29275510 , PMID:32387340 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of ALDH1L2 gene CTD PMID:28505145 Bisphenol B increases expression ISO RGD:1345617 6480464 bisphenol B results in increased expression of ALDH1L2 protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:1345617 6480464 bisphenol F results in increased expression of ALDH1L2 protein CTD PMID:34186270 cadmium atom increases expression ISO RGD:1345617 6480464 Cadmium results in increased expression of ALDH1L2 mRNA CTD PMID:21120746 carbon nanotube increases expression ISO RGD:1551620 6480464 Nanotubes, Carbon results in increased expression of ALDH1L2 mRNA CTD PMID:25554681 choline multiple interactions ISO RGD:1551620 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ALDH1L2 mRNA CTD PMID:20938992 chromium trinitrate increases expression ISO RGD:1551620 6480464 chromium nitrate results in increased expression of ALDH1L2 protein CTD PMID:22144121 clobetasol decreases expression ISO RGD:1551620 6480464 Clobetasol results in decreased expression of ALDH1L2 mRNA CTD PMID:27462272 cobalt atom multiple interactions ISO RGD:1345617 6480464 [tungsten carbide co-treated with Cobalt] results in decreased expression of ALDH1L2 mRNA CTD PMID:18078969 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of ALDH1L2 mRNA CTD PMID:24386269 copper atom decreases expression EXP 6480464 Copper results in decreased expression of ALDH1L2 mRNA CTD PMID:30556269 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of ALDH1L2 mRNA CTD PMID:30556269 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of ALDH1L2 mRNA CTD PMID:26577399 , PMID:27523638 cyclosporin A increases expression ISO RGD:1345617 6480464 Cyclosporine results in increased expression of ALDH1L2 mRNA CTD PMID:19159671 more ... dexamethasone decreases expression ISO RGD:1551620 6480464 Dexamethasone results in decreased expression of ALDH1L2 mRNA CTD PMID:22733784 diclofenac decreases expression ISO RGD:1551620 6480464 Diclofenac results in decreased expression of ALDH1L2 mRNA CTD PMID:26934552 Didecyldimethylammonium increases expression ISO RGD:1345617 6480464 didecyldimethylammonium results in increased expression of ALDH1L2 mRNA CTD PMID:32763356 dioxygen multiple interactions ISO RGD:1551620 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ALDH1L2 mRNA CTD PMID:30529165 dorsomorphin multiple interactions ISO RGD:1345617 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1345617 6480464 Doxorubicin results in decreased expression of ALDH1L2 mRNA CTD PMID:29803840 endosulfan affects expression EXP 6480464 Endosulfan affects the expression of ALDH1L2 mRNA CTD PMID:29391264 entinostat increases expression ISO RGD:1345617 6480464 entinostat results in increased expression of ALDH1L2 mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:1345617 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ALDH1L2 mRNA CTD PMID:27188386 ethanol increases expression ISO RGD:1551620 6480464 Ethanol results in increased expression of ALDH1L2 mRNA CTD PMID:30319688 ferric oxide decreases expression ISO RGD:1551620 6480464 ferric oxide analog results in decreased expression of ALDH1L2 mRNA CTD PMID:25086211 folic acid multiple interactions ISO RGD:1551620 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ALDH1L2 mRNA CTD PMID:20938992 folic acid decreases expression ISO RGD:1551620 6480464 Folic Acid results in decreased expression of ALDH1L2 mRNA CTD PMID:25629700 formaldehyde increases expression ISO RGD:1345617 6480464 Formaldehyde results in increased expression of ALDH1L2 mRNA CTD PMID:27664576 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of ALDH1L2 mRNA CTD PMID:22061828 hydroquinone increases expression ISO RGD:1345617 6480464 hydroquinone results in increased expression of ALDH1L2 mRNA CTD PMID:31256213 indometacin increases expression ISO RGD:1345617 6480464 Indomethacin results in increased expression of ALDH1L2 mRNA CTD PMID:17401462 iodide salt multiple interactions EXP 6480464 [hexabromocyclododecane co-treated with Iodides deficiency] results in decreased expression of ALDH1L2 protein CTD PMID:26795019 isobutanol multiple interactions ISO RGD:1345617 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of ALDH1L2 mRNA CTD PMID:29432896 ivermectin increases expression ISO RGD:1551620 6480464 Ivermectin results in increased expression of ALDH1L2 mRNA CTD PMID:28942281 L-methionine multiple interactions ISO RGD:1551620 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ALDH1L2 mRNA CTD PMID:20938992 lead diacetate increases expression ISO RGD:1551620 6480464 lead acetate results in increased expression of ALDH1L2 mRNA CTD PMID:25270620 lucanthone decreases expression ISO RGD:1345617 6480464 Lucanthone results in decreased expression of ALDH1L2 mRNA CTD PMID:21148553 mercury dibromide increases expression ISO RGD:1345617 6480464 mercuric bromide results in increased expression of ALDH1L2 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1345617 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ALDH1L2 mRNA CTD PMID:27188386 methapyrilene decreases methylation ISO RGD:1345617 6480464 Methapyrilene results in decreased methylation of ALDH1L2 intron CTD PMID:30157460 methylisothiazolinone decreases expression ISO RGD:1345617 6480464 2-methyl-4-isothiazolin-3-one results in decreased expression of ALDH1L2 mRNA CTD PMID:31629900 methylmercury chloride increases expression ISO RGD:1345617 6480464 methylmercuric chloride results in increased expression of ALDH1L2 mRNA CTD PMID:28001369 Mitotane increases expression ISO RGD:1345617 6480464 Mitotane results in increased expression of ALDH1L2 mRNA CTD PMID:22966885 monosodium L-glutamate multiple interactions ISO RGD:1551620 6480464 [Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of ALDH1L2 mRNA CTD PMID:20111022 N-ethyl-N-nitrosourea increases mutagenesis ISO RGD:1551620 6480464 Ethylnitrosourea results in increased mutagenesis of ALDH1L2 mRNA CTD PMID:27776689 N-methyl-4-phenylpyridinium increases expression ISO RGD:1345617 6480464 1-Methyl-4-phenylpyridinium results in increased expression of ALDH1L2 mRNA CTD PMID:24810058 N-nitrosodimethylamine decreases expression EXP 6480464 Dimethylnitrosamine results in decreased expression of ALDH1L2 mRNA CTD PMID:25380136 nickel sulfate decreases expression ISO RGD:1345617 6480464 nickel sulfate results in decreased expression of ALDH1L2 mRNA CTD PMID:22714537 nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of ALDH1L2 mRNA CTD PMID:26720608 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of ALDH1L2 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:1551620 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of ALDH1L2 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in increased expression of ALDH1L2 mRNA CTD PMID:34911549 panobinostat increases expression ISO RGD:1345617 6480464 panobinostat results in increased expression of ALDH1L2 mRNA CTD PMID:26272509 panobinostat multiple interactions ISO RGD:1345617 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ALDH1L2 mRNA CTD PMID:27188386 paraquat increases expression EXP 6480464 Paraquat results in increased expression of ALDH1L2 mRNA CTD PMID:32680482 perfluorooctanoic acid increases expression ISO RGD:1345617 6480464 perfluorooctanoic acid results in increased expression of ALDH1L2 protein CTD PMID:26879310 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of ALDH1L2 protein CTD PMID:34958885 phenylmercury acetate increases expression ISO RGD:1345617 6480464 Phenylmercuric Acetate results in increased expression of ALDH1L2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1345617 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ALDH1L2 mRNA CTD PMID:27188386 potassium chromate decreases expression ISO RGD:1551620 6480464 potassium chromate(VI) results in decreased expression of ALDH1L2 protein CTD PMID:22144121 potassium chromate decreases expression ISO RGD:1345617 6480464 potassium chromate(VI) results in decreased expression of ALDH1L2 mRNA CTD PMID:22714537 resveratrol increases expression ISO RGD:1551620 6480464 resveratrol results in increased expression of ALDH1L2 protein CTD PMID:25505154 rotenone increases expression ISO RGD:1551620 6480464 Rotenone results in increased expression of ALDH1L2 mRNA CTD PMID:19304788 rotenone decreases expression ISO RGD:1345617 6480464 Rotenone results in decreased expression of ALDH1L2 mRNA CTD PMID:29955902 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of ALDH1L2 mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO RGD:1345617 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide affects expression ISO RGD:1345617 6480464 Silicon Dioxide analog affects the expression of ALDH1L2 mRNA CTD PMID:23806026 sodium dichromate decreases expression EXP 6480464 sodium bichromate results in decreased expression of ALDH1L2 mRNA CTD PMID:25993096 Soman increases expression EXP 6480464 Soman results in increased expression of ALDH1L2 mRNA CTD PMID:19281266 sulforaphane decreases expression ISO RGD:1345617 6480464 sulforaphane results in decreased expression of ALDH1L2 mRNA CTD PMID:26833863 sunitinib increases expression ISO RGD:1345617 6480464 Sunitinib results in increased expression of ALDH1L2 mRNA CTD PMID:31533062 testosterone multiple interactions ISO RGD:1551620 6480464 1 more ... CTD PMID:33848595 testosterone decreases expression ISO RGD:1551620 6480464 Testosterone deficiency results in decreased expression of ALDH1L2 mRNA CTD PMID:33848595 tetrachloromethane increases expression ISO RGD:1551620 6480464 Carbon Tetrachloride results in increased expression of ALDH1L2 mRNA CTD PMID:27339419 , PMID:31919559 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of ALDH1L2 mRNA CTD PMID:31150632 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of ALDH1L2 mRNA CTD PMID:23411599 , PMID:34492290 titanium dioxide decreases expression ISO RGD:1551620 6480464 titanium dioxide results in decreased expression of ALDH1L2 mRNA CTD PMID:27760801 , PMID:29264374 topotecan increases expression EXP 6480464 Topotecan results in increased expression of ALDH1L2 mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of ALDH1L2 mRNA CTD PMID:25729387 trichostatin A increases expression ISO RGD:1345617 6480464 trichostatin A results in increased expression of ALDH1L2 mRNA CTD PMID:24935251 triptonide decreases expression ISO RGD:1551620 6480464 triptonide results in decreased expression of ALDH1L2 mRNA CTD PMID:33045310 trovafloxacin decreases expression ISO RGD:1551620 6480464 trovafloxacin results in decreased expression of ALDH1L2 mRNA CTD PMID:35537566 Tungsten carbide multiple interactions ISO RGD:1345617 6480464 [tungsten carbide co-treated with Cobalt] results in decreased expression of ALDH1L2 mRNA CTD PMID:18078969 tunicamycin increases expression ISO RGD:1345617 6480464 Tunicamycin results in increased expression of ALDH1L2 mRNA CTD PMID:29453283 valproic acid affects expression ISO RGD:1551620 6480464 Valproic Acid affects the expression of ALDH1L2 mRNA CTD PMID:17963808 valproic acid multiple interactions ISO RGD:1345617 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ALDH1L2 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1345617 6480464 Valproic Acid results in increased expression of ALDH1L2 mRNA CTD PMID:23179753 more ... vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of ALDH1L2 mRNA CTD PMID:23034163